Average Co-Inventor Count = 6.29
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Akebia Therapeutics, Inc. (10 from 32 patents)
2. Yale University (2 from 1,332 patents)
3. University of Cincinnati (2 from 533 patents)
4. Cincinnati Children's Hospital Medical Center (2 from 415 patents)
5. University of Houston System (1 from 595 patents)
6. Warner Chilcott Company, LLC (1 from 39 patents)
7. Kreos Capital VII (UK) Limited (1 from 1 patent)
15 patents:
1. 12478615 - PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
2. 11883386 - Prolyl hydroxylase inhibitors and methods of use
3. 11426393 - Prolyl hydroxylase inhibitors and methods of use
4. 10729681 - Prolyl hydroxylase inhibitors and methods of use
5. 10478800 - Highly ordered titania nanotube arrays for phosphoproteomics
6. RE47437 - Prolyl hydroxylase inhibitors and methods of use
7. 9920113 - Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
8. 9598370 - Prolyl hydroxylase inhibitors and methods of use
9. 9409975 - Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
10. 8940773 - Prolyl hydroxylase inhibitors and methods of use
11. 8722895 - Prolyl hydroxylase inhibitors and method of use
12. 8598210 - Prolyl hydroxylase inhibitors and methods of use
13. 8343952 - Prolyl hydroxylase inhibitors and methods of use
14. 8323671 - Prolyl hydroxylase inhibitors and methods of use
15. 7811595 - Prolyl hydroxylase inhibitors and methods of use